Open Nav

Please submit your session questions in advance at

Randy Hubbell

President & CeO

Carmell Therapeutics

Randy has been in the role of President & CEO for Carmell Therapeutics since February 2016. In that time the company has hired an expert team of former J&J executives, conducted two successful meetings with the FDA, created, validated and executed the manufacturing instructions and has raised over $8MM (of total $14MM). The company recently successfully produced three full scale batches that have passed all of the release test and will be the core content for an IND submission to the FDA in January 2019.

This speaker's sessions: